Cytotoxic Drugs The provision of Aseptically manipulated or Terminally Sterilised products (Cytotoxic & CIVAs)
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £2,059,348 (£2,471,218 inc. VAT) |
|---|---|
| Status | planned |
| Category (CPV) | 33600000 |
| OCID | ocds-h6vhtk-05251d |
description
This is supply of national dose banded (NDB) aseptically prepared and terminally sterilised 'ready -to-use' injectable products primarily for cancer or immunotherapy patient treatment. Products comprise infusion bags, pre-filed syringes and elastomeric pumps which are ordered as either batch or patient specific (PS) lines.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 23 May 2025 | Pipeline notice (UK1) | Procurement Act 2023 | 027142-2025 |
more from Great Western Hospitals NHS Foundation Trust
- National Clinical Audit and Patient Outcomes Programme (NCAPOP) - GWH 26/27 · £10,000 · 30 Jul 2026
- Architectural and Principal Designer Services for the refurbishment of Trowbridge Health Centre · 20 Jul 2026
- Medical Physics Support Services · 10 Jul 2026
- Maintenance of Cyber Holmium 100W laser · 3 Jul 2026
- Maintenance Xograph X-ray · 3 Jul 2026
- NHS Elect Membership -GWH · 2 Jul 2026
- Continuing Professional Development (CPD) / Workforce Education - GWH · 2 Jul 2026
- Tri leadership development · 2 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.